RSSDI Repository, Complications of Diabetes Demonstration RSSDI Repository, Complications of Diabetes Demonstration

Have a Question?

If you have any question you can ask below or enter what you are looking for!

  • Home/
  • Article /
  • Sixteen-years of clinically relevant dipeptidyl peptidase-IV (DPP-IV) inhibitors for treatment of type-2 diabetes: a perspective.

Sixteen-years of clinically relevant dipeptidyl peptidase-IV (DPP-IV) inhibitors for treatment of type-2 diabetes: a perspective.

Add to Collection
2014 Others RN Kushwaha, W Haq, SB Katti - Current Medicinal Chemistry, 2014 - ingentaconnect.com

Full Author : ['Kushwaha, R N', 'Haq, W', 'Katti, S B']
Journal Title : Current medicinal chemistry
Chapter : Section1
Journal Year : 2014
Cited by : 35.0

Inhibition of DPP-IV enzyme has taken centre stage as a validated drug target for type 2 diabetes therapy and as a result of research efforts done towards developing effective DPP-IV inhibitors, the first clinical candidate of this class came in focus in ..... Read More

Keywords : ["clinically relevant dipeptidyl peptidaseiv dppiv inhibitor", "treatment", "sixteenyear", "perspective", "diabetes"]
PubMed Link : https://www.ingentaconnect.com/content/ben/cmc/2014/00000021/00000035/art00003
Google Scholar Link : https://scholar.google.com/scholar?cites=10817701401431310933&as_sdt=5,34&sciodt=0,34&hl=en&num=20